Literature DB >> 12578734

The role of substance P in cerebral ischemia.

G Bruno1, F Tega, A Bruno, U Graf, F Corelli, R Molfetta, M Barucco.   

Abstract

Tackykinins are involved in the inflammatory process of a large number of diseases. The role of the tachykinins in ischemic brain injury was evaluated by the serum levels of Substance P (SP), one of the most known tachykinins and detected by a competitive enzyme immunoassay. The study was performed in 15 human females and 3 human males with typical manifestation of complete stroke (12 cases) or transient ischemic attack (6 cases). The mean SP level in the serum of patients with transient ischemic attack (0.53+/-0.25 ng/ml) and of patients with complete stroke (0.31+/-0.14 ng/ml), showed significantly higher values than in controls (0.10+/-0.02 ng/ml). Moreover, in transient ischemic attack, the SP values were significantly higher than in cerebral complete stroke. But SP levels, based on the timings of classification of patients (i.e. before 12 hours: 0.34+/-0.15 ng/ml vs. 12 to 24 hours: 0.26+/-0.11 ng/ml) with brain injury, did not show any significant difference. Both values anyway were significantly higher than in controls. Our original results demonstrate the SP increase during cerebral ischemia. Further studies are necessary to verify if SP has an effective physiopathological role in the neurological ischemic damage, or if it is only a concomitant phenomenon. Our data, if confirmed, will be particularly important, not only to improve the knowledge of cerebral ischemic injury, but also for diagnosis and therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12578734     DOI: 10.1177/039463200301600110

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


  8 in total

Review 1.  The Medical Management of Cerebral Edema: Past, Present, and Future Therapies.

Authors:  Michael R Halstead; Romergryko G Geocadin
Journal:  Neurotherapeutics       Date:  2019-10       Impact factor: 7.620

Review 2.  Substance P antagonists as a therapeutic approach to improving outcome following traumatic brain injury.

Authors:  Robert Vink; Corinna van den Heuvel
Journal:  Neurotherapeutics       Date:  2010-01       Impact factor: 7.620

Review 3.  The Role of Neurogenic Inflammation in Blood-Brain Barrier Disruption and Development of Cerebral Oedema Following Acute Central Nervous System (CNS) Injury.

Authors:  Annabel J Sorby-Adams; Amanda M Marcoionni; Eden R Dempsey; Joshua A Woenig; Renée J Turner
Journal:  Int J Mol Sci       Date:  2017-08-17       Impact factor: 5.923

Review 4.  Kinin receptor antagonists as potential neuroprotective agents in central nervous system injury.

Authors:  Emma Thornton; Jenna M Ziebell; Anna V Leonard; Robert Vink
Journal:  Molecules       Date:  2010-09-20       Impact factor: 4.411

5.  Determining the Temporal Profile of Intracranial Pressure Changes Following Transient Stroke in an Ovine Model.

Authors:  Annabel J Sorby-Adams; Anna V Leonard; Levi E Elms; Oana C Marian; Jan W Hoving; Nawaf Yassi; Robert Vink; Emma Thornton; Renée J Turner
Journal:  Front Neurosci       Date:  2019-07-09       Impact factor: 4.677

6.  Blocking neurogenic inflammation for the treatment of acute disorders of the central nervous system.

Authors:  Kate Marie Lewis; Renée Jade Turner; Robert Vink
Journal:  Int J Inflam       Date:  2013-05-29

7.  The role of substance p in ischaemic brain injury.

Authors:  Renée J Turner; Robert Vink
Journal:  Brain Sci       Date:  2013-01-30

8.  Serum Levels of Substance P and Mortality in Patients with a Severe Acute Ischemic Stroke.

Authors:  Leonardo Lorente; María M Martín; Teresa Almeida; Antonia Pérez-Cejas; Luis Ramos; Mónica Argueso; Marta Riaño-Ruiz; Jordi Solé-Violán; Mariano Hernández
Journal:  Int J Mol Sci       Date:  2016-06-22       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.